SCM
LLY icon

Soleus Capital Management’s Eli Lilly LLY Stock Holding History

Soleus Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,658
Closed -$9M – 85
2024
Q4 		$9M Sell
11,658
-7,642
-40% -$6.33M 0.57% 42
2024
Q3 		$17.1M Buy
+19,300
New +$17.4M 1.32% 26
2023
Q3 		– Sell
-4,300
Closed -$2.02M – 105
2023
Q2 		$2.02M Buy
+4,300
New +$1.8M 0.22% 75
2023
Q1 		– Sell
-39,100
Closed -$14.3M – 89
2022
Q4 		$14.3M Sell
39,100
-41,700
-52% -$14.8M 2.05% 16
2022
Q3 		$26.1M Buy
+80,800
New +$25.6M 3.55% 8
2020
Q3 		– Sell
-20,800
Closed -$3.41M – 69
2020
Q2 		$3.41M Buy
+20,800
New +$3.19M 1.95% 17

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Soleus Capital Management's LLY Position: Q1 2025 in Review

Soleus Capital Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 11,658 shares — an estimated $9M sold.

Soleus Capital Management first reported a position in LLY in Q2 2020 and held it in 6 quarters. The position peaked at $26.1M in Q3 2022. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Soleus Capital Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Soleus Capital Management sold 11,658 Eli Lilly shares in Q1 2025, an estimated $9M.
  • Soleus Capital Management first reported a position in Eli Lilly in Q2 2020 and held it in 6 quarters.
  • Soleus Capital Management's Eli Lilly position peaked at $26.1M in Q3 2022.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Soleus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.